Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Jul 2026 for Indivior Pharmaceuticals, Inc., €668k.
Filing timeline
BuySaleChristian Heidbreder
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christian Heidbreder: trading record in brief
All filings by Christian Heidbreder on record concern Indivior Pharmaceuticals, Inc. In total, 4 filings cover trades dated from 10 February 2026 to 10 July 2026.
Sales make up the whole of the open-market record (1 sale, €668k). Other entries cover 2 share grants and 1 option exercise.
Most recently, on 13 July 2026, the filings show an open-market sale worth €668k in Indivior Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christian Heidbreder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
18,586 shares@ US$41.14Common StockSEC:0002014639-26-000011:0
101,544 sharesCommon StockSEC:0002014639-26-000006:0
33,622 shares0Common StockSEC:0002014639-26-000004:0
3 of 3 declarations
